文献速递垂体与肾上腺疾病

COVID-19大流行对肾上腺功能不全患者自我报告结局的影响

The Impact of the COVID-19 Pandemic on Self-Reported Outcomes in Patients With Adrenal Insufficiency.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

这项前瞻性纵向调查研究在2个三级中心纳入342例肾上腺功能不全(AI)患者,采用患者中心问卷评估。研究发现大流行期间每日糖皮质激素剂量和肾上腺危象次数未变,但患者报告AI经济影响更大(34% vs 23%,P=0.006)和就医困难更多(31% vs 7%,P<0.0001),约三分之一患者报告管理AI有困难。

要点

  • 大流行期间AI患者每日糖皮质激素剂量和肾上腺危象次数未变。
  • 患者报告AI经济影响(34% vs 23%)和就医困难(31% vs 7%)增加。
  • 年轻、女性、就医可及性差等患者管理AI困难风险更高。

核心结论

  • 约三分之一AI患者报告大流行期间管理AI有困难,尤其在年轻、女性及就医可及性差的患者中。

研究设计与样本

  • 前瞻性纵向调查研究,在2个三级中心纳入342例肾上腺功能不全患者,使用患者中心问卷。

主要发现

  • 与疫情前相比,每日糖皮质激素剂量和肾上腺危象次数无变化。
  • 大流行期间患者报告AI经济影响更高(34% vs 23%,P=0.006)。
  • 大流行期间患者报告就医困难更多(31% vs 7%,P<0.0001)。
  • 约三分之一患者报告大流行期间管理AI有困难。
  • 调整AI病程和亚型后,年轻患者(OR 2.3,95%CI 1.3-4.1)、女性(OR 3.7,95%CI 1.9-7.1)、就医可及性差(OR 4.2,95%CI 2.3-7.7)、缺乏良好保险支持(OR 2.8,95%CI 1.3-5.9)及经济影响较高(OR 2.3,95%CI 1.3-4.3)者报告管理AI困难更大。

关键数值与推荐

  • 管理AI困难者更可能报告焦虑评分较高(≥8)(OR 3.0,95%CI 1.3-6.9)。
  • 疫情前躯体健康总评较低(OR 4.9,95%CI 2.2-11.0)和心理健康总评较低(OR 4.1,95%CI 1.8-9.5)者更可能报告管理AI困难。

临床怎么用

  • 临床应关注AI患者在大流行期间的经济负担和就医可及性,尤其对年轻、女性及保险支持不足者加强管理支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The COVID-19 pandemic has impacted healthcare environment. OBJECTIVE: To determine the impact of the pandemic on self-reported outcomes in patients with adrenal insufficiency (AI). DESIGN AND SETTING: Prospective longitudinal survey study at 2 tertiary centers. PARTICIPANTS: Patients with AI. INTERVENTION: Patient-centered questionnaire. MAIN OUTCOME MEASURES: Depression Anxiety Stress Scales-21, Short Form-36, and AI self-management. RESULTS: Of 342 patients, 157 (46%) had primary AI, 109 (32%) had secondary AI, and 76 (22%) had glucocorticoid-induced AI. When compared to prepandemic, daily glucocorticoid dose and number of adrenal crises did not change. However, patients reported a higher financial impact from AI (34% vs 23%, P = 0.006) and difficulty accessing medical care (31% vs 7%, P < 0.0001) during the pandemic. A third of patients reported difficulty managing AI during the pandemic. After adjusting for duration and subtypes of AI, younger patients [odds ratio (OR) 2.3, CI 95% 1.3-4.1], women (OR 3.7, CI 95% 1.9-7.1), poor healthcare access(OR 4.2, CI 95% 2.3-7.7), lack of good insurance support (OR 2.8, CI 95% 1.3-5.9), and those with a higher financial impact (OR 2.3, CI 95% 1.3-4.3) reported greater difficulties managing AI. Patients were more likely to report a higher anxiety score (≥8) if they found managing AI challenging during the pandemic (OR 3.0, CI 95% 1.3-6.9), and had lower Physical Component Summary (OR 4.9, CI 95% 2.2-11.0) and Mental Component Summary (OR 4.1, CI 95% 1.8-9.5) scores prior to the pandemic. CONCLUSIONS: A third of patients with AI reported difficulties with management of AI during the pandemic, particularly in younger patients, women, and those with poor healthcare access.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li D, Suresh M, Abbondanza T, et al. The Impact of the COVID-19 Pandemic on Self-Reported Outcomes in Patients With Adrenal Insufficiency. J Clin Endocrinol Metab. 2021. PMID: 34042985. doi:10.1210/clinem/dgab334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。